SM
Therapeutic Areas
Emcure Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Biosimilar Portfolio (e.g., Filgrastim) | Chemotherapy-induced Neutropenia | Commercial |
| Complex Generics/Injectables | Various | Development/ANDA Filing |
| mRNA Vaccine Platform (via Gennova) | Infectious Diseases (e.g., COVID-19) | Commercial/Development |